These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 20640913
21. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia. Homer VM, Brennan SO, Ockelford P, George PM. Thromb Haemost; 2002 Sep; 88(3):427-31. PubMed ID: 12353071 [Abstract] [Full Text] [Related]
22. [Functional study of abnormal fibrinogen caused by Arg275His mutation in fibrinogen γ chain]. Zhou JY, Wang XF, Ding QL, Xu GQ, Zhang LW, Dai J, Lu YL, Xi XD, Wang HL. Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):190-4. PubMed ID: 23683413 [Abstract] [Full Text] [Related]
23. Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene. Monaldini L, Asselta R, Duga S, Peyvandi F, Ghosh K, Malcovati M, Tenchini ML. Haematologica; 2006 May; 91(5):628-33. PubMed ID: 16670068 [Abstract] [Full Text] [Related]
24. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E, de Mazancourt P, Maghzal GJ, Brennan SO, Mosesson MW. Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [Abstract] [Full Text] [Related]
25. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module. Asselta R, Robusto M, Braidotti P, Peyvandi F, Nastasio S, D'Antiga L, Perisic VN, Maggiore G, Caccia S, Duga S. J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544 [Abstract] [Full Text] [Related]
26. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P. J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717 [Abstract] [Full Text] [Related]
27. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I. Terasawa F, Kani S, Hongo M, Okumura N. Thromb Res; 2006 Jun; 118(5):651-61. PubMed ID: 16412498 [Abstract] [Full Text] [Related]
28. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I). Mukai S, Ikeda M, Takezawa Y, Sugano M, Honda T, Okumura N. Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395 [Abstract] [Full Text] [Related]
35. Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype. Simurda T, Brunclikova M, Asselta R, Caccia S, Zolkova J, Kolkova Z, Loderer D, Skornova I, Hudecek J, Lasabova Z, Stasko J, Kubisz P. Int J Mol Sci; 2020 Jun 29; 21(13):. PubMed ID: 32610551 [Abstract] [Full Text] [Related]